EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,798,543 | +2730.1% | 480,576 | +2888.8% | 0.02% | +1600.0% |
Q1 2024 | $381,555 | -1.1% | 16,079 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $385,735 | -84.7% | 16,079 | -86.1% | 0.00% | -85.7% |
Q3 2023 | $2,519,218 | +564.6% | 115,296 | +481.2% | 0.01% | +600.0% |
Q2 2023 | $379,066 | -98.6% | 19,836 | -98.8% | 0.00% | -99.3% |
Q4 2022 | $26,802,696 | +30.6% | 1,670,991 | +27.7% | 0.14% | +17.2% |
Q3 2022 | $20,522,000 | +279.0% | 1,308,782 | +403.2% | 0.12% | +205.0% |
Q2 2022 | $5,415,000 | +1014.2% | 260,084 | +879.2% | 0.04% | +900.0% |
Q4 2021 | $486,000 | -49.4% | 26,561 | -37.5% | 0.00% | -73.3% |
Q1 2021 | $961,000 | -45.1% | 42,526 | -40.6% | 0.02% | -40.0% |
Q3 2020 | $1,752,000 | -66.4% | 71,642 | -67.4% | 0.02% | -67.1% |
Q2 2020 | $5,210,000 | +1943.1% | 219,449 | +1382.5% | 0.08% | +660.0% |
Q1 2020 | $255,000 | +15.9% | 14,803 | +19.2% | 0.01% | -93.2% |
Q3 2019 | $220,000 | -30.6% | 12,416 | -16.3% | 0.15% | +96.0% |
Q2 2019 | $317,000 | +71.4% | 14,832 | +41.7% | 0.08% | +200.0% |
Q3 2018 | $185,000 | – | 10,465 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |